Welcome to LookChem.com Sign In|Join Free

CAS

  • or

539-86-6

Post Buying Request

539-86-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

539-86-6 Usage

Description

Different sources of media describe the Description of 539-86-6 differently. You can refer to the following data:
1. Allicin is one of the major allergens in garlic (Allium sativum L.). It is responsible of the characteristical fiavour of the bulbs.
2. Allicin is a natural product originally isolated from A. sativum that has wide-ranging biological effects including antioxidative, anticancer, antimicrobial, and antifungal activities. It inhibits the cysteine proteases cathepsin B and L, facipain 2, and rhodesain with Ki values of 8.6 and 9.3, 1.04, and 5.31 μM, respectively. It shows antiparasitic activity against P. falciparum (IC50 = 5.2 μM) and T. b. brucei (IC50 = 13.8 μM), the parasites that cause malaria and African sleeping sickness, respectively. Allicin (5-10 μM) dose-dependently inhibits cell adhesion, invasion, and migration in various lung adenocarcinoma cell lines. It also alters the balance of tissue inhibitors of matrix metalloproteinases (TIMPs) and matrix metalloproteinases (MMPs), decreases phosphorylation of Akt, and decreases PI3K/Akt signaling.

Physical properties

Appearance: Light yellow powder or light yellow oily liquid, with strong irritating odor. Unstable and light, heat, and organic solvents will easily degrade it into a variety of sulfur-containing organic compounds. Solubility: Its solubility is about 2.5% in the 10?°C water. Soluble in ethanol, ether, benzene, and other organic solvents. Boiling point: 80–85?°C (0.2?kPa). Relative density of d20?=?1.112; refractive index nD 20 ?=?1.561.

History

As the main active substance of garlic, garlic was separated by Cavallito and Bailey in 1944 from crushed garlic. Cavallito firstly clarified the physical properties and chemical structure of the scent of garlic.Fresh garlic does not contain free allicin but only its precursor material alliin. When the garlic undergoes physical mechanical crushing, garlic alliinase is activated and catalyzes the breakdown of alliin into allicin.The reported preparation methods of allicin contain extraction, biosynthesis, and chemical synthesis. Chemical synthesis starts from raw material of diallyldisulfides, m-chloroperoxy benzoic acid to get crude allicin. According to the United States patent report, biosynthesis preparation of allicin comes from natural sources or synthetic, after it is made into a certain concentration of aqueous solution, it is converted into allicin by reaction with alliinase. Extraction of allicin with low boiling nonpolar solvent can acquire pure allicin, but it must be stored at ?70?°C to prevent from decomposing.

Uses

Allicin is naturally formed by the action of the enzyme allicinase on alliin when the tissue of the garlic bulb is disrupted. Allicin shows antibacterial activity.

Definition

An antibacterial substance extracted from garlic (allium).

Indications

This product conforms to the national standards for chemical drugs. The current clinical used forms are allicin injection, garlic instant kelp capsule, etc. It is used clinically mainly for anti-pathogenic microbial infection, anti-tumor, and anti-dilation of blood vessels. It could also be used for the treatment of periodontitis and ulcerative colitis.

Synthesis Reference(s)

Journal of the American Chemical Society, 106, p. 8295, 1984 DOI: 10.1021/ja00338a049

Contact allergens

Allicin is one of the major allergens in garlic (Allium sativum L.). It is responsible for the characteristic flavor of the bulbs and has immunomodulating and antibacterial properties.

Pharmacology

Allicin has a broad spectrum of pharmacological activities, such as antibacterial, antiviral, anticancer, decreasing the blood pressure, and inhibition of platelet aggregation.2. The Effect on Heart and Cerebral Vessels Allicin exerts a protective effect on the heart and cerebral vessels through reducing plasma total cholesterol, lowering blood pressure, inhibition of platelet activity, and reducing hematocrit and blood viscosity. Allicin increases the activity of inducible nitric oxide synthetase (iNOS) and boosts the NO level, which results in the vasodilation. In vitro study also found that allicin’s vasodilation is related to NO, and allicin can improve the level of iNOS and NO in platelet and placental villi as well as choriocarcinoma. In addition, allicin administration effectively reverses hyperlipidemia and atherosclerosis, inhibits lipid peroxidation, and reduces the level of glutathione decomposition and superoxide dismutase and peroxidase activity in high cholesterol-fed rats.3. Anticancer Allyl sulfide, the active ingredient of allicin, shows anticancer effect. Epidemiological investigation and experimental studies have shown that allicin has a significant inhibitory effect on gastric, colon, liver, and lung cancers. Experimental results show that allicin improves the cellular immune function of cancer patients. Alliin is the precursor of allicin, which also has significant antitumor activity. In the 1980s, it was found that the growth of S180 tumor in mice was significantly inhibited by alliin injection or garlic thionine. Meanwhile, alliin could selectively inhibit the reduction synthesis of reduced glutathione (GSH)-dependent prostaglandin E2?in gland cells.

Clinical Use

Allicin shows inhibitory effects on infections caused by bacteria, fungi, and virus. Clinical studies reported that allicin has cured 23 Candida albicans-infected patients . Combining allicin with surgery had cured ten patients with maxillary sinus aspergillosis. Good results for the treatment of chronic gastritis, peptic ulcer, chronic colitis, and fatty liver were achieved after allicin administration. Allicin is also capable of eliminating oxygen free radical ion. In addition, allicin can reduce the nitrite- and nitrate-reducing bacteria, and taking garlic could benefit chronic symptoms in stomach, such as stomach discomfort, fullness pain, acid reflux, heating, burning and loss of appetite, and so on.

Anticancer Research

For allicin, a reduction of tumoral cell proliferation was reported by Misharina et al.(2013).

Check Digit Verification of cas no

The CAS Registry Mumber 539-86-6 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,3 and 9 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 539-86:
(5*5)+(4*3)+(3*9)+(2*8)+(1*6)=86
86 % 10 = 6
So 539-86-6 is a valid CAS Registry Number.
InChI:InChI=1/C6H10OS2/c1-3-5-8-9(7)6-4-2/h3-4H,1-2,5-6H2

539-86-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name allicin

1.2 Other means of identification

Product number -
Other names AllS(O)SAll

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:539-86-6 SDS

539-86-6Synthetic route

S‐allyl‐L‐cysteine sulfoxide
17795-27-6

S‐allyl‐L‐cysteine sulfoxide

allicin
539-86-6

allicin

Conditions
ConditionsYield
With water extract of garlic In water at 20℃; Enzymatic reaction;99%
diallyl disulphide
2179-57-9

diallyl disulphide

allicin
539-86-6

allicin

Conditions
ConditionsYield
With 3,3-dimethyldioxirane In acetone at -50 - -20℃; for 0.75h; Product distribution / selectivity; Inert atmosphere;96%
With Peroxyformic acid In methanol at 0℃; for 0.25h; Reagent/catalyst;92%
With peracetic acid; sodium carbonate In chloroform at 0℃; 1.) 30 min; 2.) 30 min;90%
C14H30OSSi

C14H30OSSi

allicin
539-86-6

allicin

Conditions
ConditionsYield
With 3-chloro-benzenecarboperoxoic acid In dichloromethane at -78℃; for 3h;71%
C13H28OSSi

C13H28OSSi

allicin
539-86-6

allicin

Conditions
ConditionsYield
With 3-chloro-benzenecarboperoxoic acid In dichloromethane at -78℃; for 3h; Reagent/catalyst; Solvent; Temperature;64%
C10H22OSSi

C10H22OSSi

allicin
539-86-6

allicin

Conditions
ConditionsYield
With 3-chloro-benzenecarboperoxoic acid In dichloromethane at -78℃; for 3h; Reagent/catalyst; Solvent; Temperature;29%
peracetic acid
79-21-0

peracetic acid

diallyl disulphide
2179-57-9

diallyl disulphide

chloroform
67-66-3

chloroform

allicin
539-86-6

allicin

Perbenzoic acid
93-59-4

Perbenzoic acid

diallyl disulphide
2179-57-9

diallyl disulphide

chloroform
67-66-3

chloroform

allicin
539-86-6

allicin

Conditions
ConditionsYield
enzymatischer Abbau durch Alliinase; (+)(2R)-2-amino-3-allylsulfinyl-propionic acid;
durch Einwirkung von Alliinase;
alliinase rich garlic juice extract at 30℃; for 3h; Product distribution / selectivity; Enzymatic reaction;
With Petiveria alliacea L. alliinase; Petiveria alliacea lachrymatory factor synthase; pyridoxal 5'-phosphate; NAD at 20℃; for 0.333333h; pH=8; aq. phosphate buffer;
propylene sulphide
1072-43-1

propylene sulphide

allicin
539-86-6

allicin

Conditions
ConditionsYield
With sodium periodate
S-allyl cysteine
21593-77-1, 49621-03-6

S-allyl cysteine

A

diallyl disulphide
2179-57-9

diallyl disulphide

B

allicin
539-86-6

allicin

C

bis-2-propenyl thiosulfonate
29418-05-1

bis-2-propenyl thiosulfonate

D

sodium pyruvate
113-24-6

sodium pyruvate

Conditions
ConditionsYield
With nitrogen(II) oxide In water for 24h; Ambient temperature; Yield given. Yields of byproduct given;
S-allyl cysteine
21593-77-1, 49621-03-6

S-allyl cysteine

A

diallyl disulphide
2179-57-9

diallyl disulphide

B

allicin
539-86-6

allicin

C

bis-2-propenyl thiosulfonate
29418-05-1

bis-2-propenyl thiosulfonate

D

2-oxo-propionic acid
127-17-3

2-oxo-propionic acid

Conditions
ConditionsYield
With nitrogen(II) oxide; trifluoroacetic acid In water for 5h; Mechanism; Ambient temperature; other time; also in absence of CF3COOH;
allyl bromide
106-95-6

allyl bromide

allicin
539-86-6

allicin

Conditions
ConditionsYield
With sodium hydrogensulfide; dihydrogen peroxide Yield given. Multistep reaction;
Alliin
556-27-4

Alliin

allicin
539-86-6

allicin

Conditions
ConditionsYield
With immobilized alliinase
Immobilized alliinase column;
With alliinase In water at 25 - 35℃; for 0.5h; pH=6.5 - 8.5; Time; Enzymatic reaction; Inert atmosphere;
prop-2-ene-1-thiol
870-23-5

prop-2-ene-1-thiol

A

diallyl disulphide
2179-57-9

diallyl disulphide

B

allicin
539-86-6

allicin

Conditions
ConditionsYield
With dihydrogen peroxide for 0.25h; Product distribution / selectivity;
(S)-allyl-L-cysteine sulfoxide
1195577-61-7

(S)-allyl-L-cysteine sulfoxide

A

allicin
539-86-6

allicin

B

2-oxo-propionic acid
127-17-3

2-oxo-propionic acid

Conditions
ConditionsYield
With alliinase In water at 25 - 35℃; for 0.5h; pH=6.5 - 8.5; Enzymatic reaction; Inert atmosphere;

A

allicin
539-86-6

allicin

B

2-oxo-propionic acid
127-17-3

2-oxo-propionic acid

Conditions
ConditionsYield
With pyridoxal 5'-phosphate; water; Allium sativum alliinase Enzymatic reaction;
allicin
539-86-6

allicin

6-(trifluoromethyl)benzo[d]thiazole-2-thiol
401567-22-4

6-(trifluoromethyl)benzo[d]thiazole-2-thiol

2-(allyldisulfanyl)-6-(trifluoromethyl)benzo[d]thiazole

2-(allyldisulfanyl)-6-(trifluoromethyl)benzo[d]thiazole

Conditions
ConditionsYield
In methanol at 20℃;97%
allicin
539-86-6

allicin

6-ethoxy-2-mercaptobenzothiazole
120-53-6

6-ethoxy-2-mercaptobenzothiazole

2-(allyldisulfanyl)-6-ethoxybenzo[d]thiazole

2-(allyldisulfanyl)-6-ethoxybenzo[d]thiazole

Conditions
ConditionsYield
In methanol at 20℃;95%
allicin
539-86-6

allicin

l-cysteine hydrochloride
52-89-1

l-cysteine hydrochloride

(R)-2-amino-3-(allyldithio)propionic acid
2281-22-3

(R)-2-amino-3-(allyldithio)propionic acid

Conditions
ConditionsYield
With sodium hydrogencarbonate In water for 0.33h;90%
With sodium hydrogencarbonate
With sodium hydrogencarbonate In water for 0.33h; pH=6;480 mg
2-mercapto-6-methylbenzothiazole
2268-79-3

2-mercapto-6-methylbenzothiazole

allicin
539-86-6

allicin

2-(allyldisulfanyl)-6-methylbenzo[d]thiazole

2-(allyldisulfanyl)-6-methylbenzo[d]thiazole

Conditions
ConditionsYield
In methanol at 20℃;90%
allicin
539-86-6

allicin

2-Mercaptobenzothiazole
149-30-4

2-Mercaptobenzothiazole

2-(allyldisulfanyl)benzothiazole

2-(allyldisulfanyl)benzothiazole

Conditions
ConditionsYield
In methanol at 20℃;90%
allicin
539-86-6

allicin

6-mercaptopurine riboside
15639-75-5

6-mercaptopurine riboside

S-allylthio-6-mercaptopurine riboside

S-allylthio-6-mercaptopurine riboside

Conditions
ConditionsYield
In ethanol for 4h; pH=7.2; aq. phosphate buffer;85%
In ethanol; water at 4℃; for 4h; pH=7.2; Phosphate buffer;85%
Conditions
ConditionsYield
With sodium hydrogencarbonate In ethanol; water pH=8.0 - 8.4;80%
With sodium hydrogencarbonate In ethanol; water at 20℃; for 10h; pH=8 - 8.4;80%
In ethanol at 20℃; pH=6.5; aq. phosphate buffer;
allicin
539-86-6

allicin

(3,5,6-Trimethyl-pyrazin-2-yl)-methanethiol
184826-39-9

(3,5,6-Trimethyl-pyrazin-2-yl)-methanethiol

2-((allyldisulfanyl)methyl)-3,5,6-trimethylpyrazine

2-((allyldisulfanyl)methyl)-3,5,6-trimethylpyrazine

Conditions
ConditionsYield
With sodium hydrogencarbonate In ethanol; water at 60℃; for 10h; pH=8 - 8.4;49%
allicin
539-86-6

allicin

6-chloro-2-mercaptobenzothiazole
51618-29-2

6-chloro-2-mercaptobenzothiazole

2-(allyldisulfanyl)-6-chlorobenzo[d]thiazole

2-(allyldisulfanyl)-6-chlorobenzo[d]thiazole

Conditions
ConditionsYield
In methanol at 20℃;40%
allicin
539-86-6

allicin

6-chloro-2-mercaptobenzoxazole
22876-20-6

6-chloro-2-mercaptobenzoxazole

2-(allyldisulfanyl)-6-chlorobenzoxazole

2-(allyldisulfanyl)-6-chlorobenzoxazole

Conditions
ConditionsYield
In methanol at 20℃;40%
allicin
539-86-6

allicin

2-mercapto-5-metossi-benzossazolo
49559-83-3

2-mercapto-5-metossi-benzossazolo

2-(allyldisulfanyl)-5-methoxybenzoxazole

2-(allyldisulfanyl)-5-methoxybenzoxazole

Conditions
ConditionsYield
In methanol at 20℃;31%
allicin
539-86-6

allicin

phenylmethanethiol
100-53-8

phenylmethanethiol

1-allyl-2-benzyldisulfane

1-allyl-2-benzyldisulfane

Conditions
ConditionsYield
In methanol at 20℃;30%
allicin
539-86-6

allicin

Thiamine hydrochloride
67-03-8

Thiamine hydrochloride

N-(2-allyldisulfanyl-4-hydroxy-1-methyl-but-1-en-t-yl)-N-(4-amino-2-methyl-pyrimidin-5-ylmethyl)-formamide
554-44-9

N-(2-allyldisulfanyl-4-hydroxy-1-methyl-but-1-en-t-yl)-N-(4-amino-2-methyl-pyrimidin-5-ylmethyl)-formamide

Conditions
ConditionsYield
With sodium hydroxide; ethanol; water bei pH 8;
diallyl disulphide
2179-57-9

diallyl disulphide

allicin
539-86-6

allicin

A

2-(2',3'-dithia-5'-hexenyl)-3,4-dihydro-2H-thiopyran

2-(2',3'-dithia-5'-hexenyl)-3,4-dihydro-2H-thiopyran

B

3-(2',3'-dithia-5'-hexenyl)-3,4-dihydro-2H-thiopyran

3-(2',3'-dithia-5'-hexenyl)-3,4-dihydro-2H-thiopyran

Conditions
ConditionsYield
at 100℃; for 0.25h; Product distribution; Mechanism; copyrolysis;A 0.22 % Chromat.
B 0.26 % Chromat.
L-Cysteine
52-90-4

L-Cysteine

allicin
539-86-6

allicin

(R)-2-amino-3-(allyldithio)propionic acid
2281-22-3

(R)-2-amino-3-(allyldithio)propionic acid

Conditions
ConditionsYield
In water 1.) r.t., 40 min, 2.) 0 deg C, overnight; Yield given;
In water for 0.5h;5.7 mmol
In water at 23 - 25℃;
In water at 20℃; for 2h;
allicin
539-86-6

allicin

A

3-vinyl-4H-<1,2>-dithiin
62488-53-3

3-vinyl-4H-<1,2>-dithiin

B

diallyl disulphide
2179-57-9

diallyl disulphide

C

diallyl trisulfide
2050-87-5

diallyl trisulfide

D

2‐ethenyl‐4H‐1,3‐dithiine
80028-57-5

2‐ethenyl‐4H‐1,3‐dithiine

Conditions
ConditionsYield
In chloroform-d1 at 25℃; for 144h;A 0.008 g
B 0.03 g
C 0.01 g
D 0.015 g
allicin
539-86-6

allicin

A

3-vinyl-4H-<1,2>-dithiin
62488-53-3

3-vinyl-4H-<1,2>-dithiin

B

diallyl disulphide
2179-57-9

diallyl disulphide

C

diallyl trisulfide
2050-87-5

diallyl trisulfide

D

2‐ethenyl‐4H‐1,3‐dithiine
80028-57-5

2‐ethenyl‐4H‐1,3‐dithiine

E

(Z)-ajoene
92285-00-2

(Z)-ajoene

F

(E)-ajoene
92284-99-6

(E)-ajoene

Conditions
ConditionsYield
at 37℃; for 48h; Product distribution; other temperatures, other times;
allicin
539-86-6

allicin

A

4,5,9-trithiadodeca-1,11-diene 9-oxide
104228-61-7

4,5,9-trithiadodeca-1,11-diene 9-oxide

B

(E)-ajoene
92284-99-6

(E)-ajoene

Conditions
ConditionsYield
With acetic acid at 25℃; for 120h;A 0.220 g
B 0.024 g
allicin
539-86-6

allicin

A

(Z)-ajoene
92285-00-2

(Z)-ajoene

B

(E)-ajoene
92284-99-6

(E)-ajoene

Conditions
ConditionsYield
In water; acetone at 63 - 64℃; for 4h; Mechanism; Product distribution; Heating; in water-benzene, 37 deg C, 48 h;
In water; benzene at 37℃; for 48h; Heating; Yield given. Yields of byproduct given. Title compound not separated from byproducts;
In water; acetone for 4h; Heating; Yield given. Yields of byproduct given;

539-86-6Relevant articles and documents

Analysis of responses of allicin, a compound from garlic, in the pulmonary vascular bed of the cat and in the rat

Kaye, Alan D.,Nossaman, Bobby D.,Ibrahim, Ikhlass N.,Feng, Chang J.,McNamara, Dennis B.,et al.

, p. 21 - 26 (1995)

Allicin, diallyl disulfide-oxide, an active ingredient released from garlic is a systemic vasodilator that acts by an unknown mechanism. In the present experiments, pulmonary vascular responses to allicin (0.1-1.0 mg) were studied in the intact-chest anesthetized cat and in the isolated lung of the rat under constant flow conditions. When baseline tone in the pulmonary vascular bed of the cat was raised with U46619 (11α,9α-epoxymethano-9α,11β-dideoxyprostaglandin F2α), intralobar injections of allicin produced dose-related decreases in pulmonary arterial pressure without changing left atrial pressure indicating that allicin had significant vasodilator activity in the pulmonary vascular bed when tone was increased experimentally. Allicin also decreased systemic arterial pressure in a dose-related manner. In terms of relative vasodilator activity in the cat, allicin was 100-fold less potent than sodium nitroprusside and many orders of magnitude less potent than isoproterenol. In the cat, vasodilator responses to allicin were unchanged by methylene blue or Nω-nitro-L-arginine methyl ester. Allicin also significantly diminished the pulmonary pressor response to ventilatory hypoxia in the isolated perfused rat lung. These data show that allicin has significant vasodilator activity in the pulmonary vascular bed of the cat and the rat. The present data suggest that pulmonary vasodilator responses to allicin are independent of the synthesis of endothelial-derived relaxing factor or the activation of soluble guanylate cyclase.

Therapeutic effect and mechanism study of L-cysteine derivative 5P39 on LPS-induced acute lung injury in mice

He, Yanting,Zhao, Yalei,Feng, Yuchen,Ren, Anqi,Zhang, Yunyi,Wang, Yang,Li, Hong

, (2020)

Organosulfur compounds, such as L-cysteine, allicin and other sulfur-containing organic compounds in Allium species, have been proposed to possess many important physiological and pharmacological functions. A novel L-cysteine derivative, t-Butyl S-allylthio-L-cysteinate (5P39), was designed and synthesized by combining L-cysteine derivative and allicin pharmacophore through a disulfide bond. This study aimed to explore the effects and mechanisms of 5P39 on lipopolysaccharide (LPS)-induced acute lung injury (ALI) in mice. At the experimental concentration (5, 10 and 20 μM), 5P39 suppressed the excessive secretion of nitric oxide (NO) and interleukin-6 (IL-6) in mice peritoneal macrophages stimulated by LPS. A mouse model of ALI was established by tracheal instillation of LPS for 2 h before 5P39 (30 and 60 mg/kg) administration. The results showed that 5P39 treatment down-regulated the wet/dry weight ratio (W/D ratio) of lungs and reduced the protein concentration, the number of total cells as well as the myeloperoxidase (MPO) activity in bronchoalveolar lavage fluid (BALF). 5P39 administration improved the histopathological changes of lungs in ALI mice with the decreased levels of pro-inflammatory cytokines in BALF. The inhibitory effects of 5P39 on the toll-like receptor 4 (TLR4) expression and macrophages accumulation in lung tissues were observed by immunohistochemistry. Additionally, 5P39 significantly attenuated the LPS-activated high expression of key proteins in TLR4/MyD88 signaling pathway. Taken together, the present study showed that 5P39 effectively alleviate the severity of ALI, and its mechanism might relate to the inhibition of LPS-activated TLR4/MyD88 signaling pathway, demonstrating a promising potential for further development into an anti-inflammatory drug candidate.

Hypochlorous acid scavenging activities of thioallyl compounds from garlic

Argueello-Garcia, Raul,Medina-Campos, Omar N.,Perez-Hernandez, Nury,Pedraza-Chaverri, Jose,Ortega-Pierres, Guadalupe

, p. 11226 - 11233 (2010)

The hypochlorous acid (HOCl) scavenging capacities of 10 garlic compounds containing modifications in the thioallyl group (-S-CH2CH=CH 2) were determined by a catalase protection assay, and the corresponding structure-activity relationships using molecular descriptors were calculated. This scavenging activity was enhanced by increasing the number of S atoms or by the alanyl group (-CH2CH-NH2-COOH) and decreased in the absence of the C=C bond or in the presence of a sulfoxide group in the thioallyl group. Interestingly, S-allylcysteine and its corresponding sulfoxide (alliin) showed the highest and lowest HOCl-scavenging capacities, respectively. Quantitative modeling by multiple regression analysis and partial least-squares projections showed that the topological descriptor polar surface area and two electronic properties, namely, highest occupied molecular orbital and total energy, contributed mainly to variations in the HOCl scavenging activity of thioallyl compounds. These observations provide new insights on the antioxidant mechanism of garlic derivatives in processes involving HOCl production.

Allium sativum extract chemical composition, antioxidant activity and antifungal effect against meyerozyma guilliermondii and rhodotorula mucilaginosa causing onychomycosis

Parvu, Marcel,Mo?, C?t?lin A.,Parvu, Alina E.,Mircea, Cristina,Stoeber, Leander,Ro?ca-Casian, Oana,?igu, Adrian B.

, (2019)

Onychomycosis is a major health problem due to its chronicity and resistance to therapy. Because some cases associate paronychia, any therapy must target the fungus and the inflammation. Medicinal plants represent an alternative for onychomycosis control. In the present work the antifungal and antioxidant activities of Alium sativum extract against Meyerozyma guilliermondii (Wick.) Kurtzman & M. Suzuki and Rhodotorula mucilaginosa (A. J?rg.) F.C. Harrison, isolated for the first time from a toenail onychomycosis case, were investigated. The fungal species were confirmed by DNA molecular analysis. A. sativum minimum inhibitory concentration (MIC) and ultrastructural effects were examined. At the MIC concentration (120 mg/mL) the micrographs indicated severe structural alterations with cell death. The antioxidant properties of the A. sativum extract were evaluated is a rat turpentine oil induced inflammation, and compared to an anti-inflammatory drug, diclofenac, and the main compound from the extract, allicin. A. sativum reduced serum total oxidative status, malondialdehyde and nitric oxide production, and increased total thiols. The effects were comparable to those of allicin and diclofenac. In conclusion, the garlic extract had antifungal effects against M. guilliermondii and R. mucilaginosa, and antioxidant effect in turpentine-induced inflammation. Together, the antifungal and antioxidant activities support that A. sativum is a potential alternative treatment in onychomycosis.

Allicin induces thiol stress in bacteria through S-allylmercapto modification of protein cysteines

Müller, Alexandra,Eller, Jakob,Albrecht, Frank,Prochnow, Pascal,Kuhlmann, Katja,Bandow, Julia Elisabeth,Slusarenko, Alan John,Leichert, Lars Ingo Ole

, p. 11477 - 11490 (2016)

Allicin (diallyl thiosulfinate) from garlic is a highly potent natural antimicrobial substance. It inhibits growth of a variety of microorganisms, among them antibiotic-resistant strains. However, the precise mode of action of allicin is unknown. Here, we show that growth inhibition of Escherichia coli during allicin exposure coincides with a depletion of the glutathione pool and S-allylmercapto modification of proteins, resulting in overall decreased total sulfhydryl levels. This is accompanied by the induction of the oxidative and heat stress response. We identified and quantified the allicin-induced modification S-allylmercaptocysteine for a set of cytoplasmic proteins by using a combination of label-free mass spectrometry and differential isotope-coded affinity tag labeling of reduced and oxidized thiol residues. Activity of isocitrate lyase AceA, an S-allylmercapto-modified candidate protein, is largely inhibited by allicin treatment in vivo. Allicin-induced protein modifications trigger protein aggregation, which largely stabilizes RpoH and thereby induces the heat stress response. At sublethal concentrations, the heat stress response is crucial to overcome allicin stress. Our results indicate that the mode of action of allicin is a combination of a decrease of glutathione levels, unfolding stress, and inactivation of crucial metabolic enzymes through S-allylmercapto modification of cysteines.

Subinhibitory concentrations of allicin decrease uropathogenic escherichia coli (UPEC) biofilm formation, adhesion ability, and swimming motility

Yang, Xiaolong,Sha, Kaihui,Xu, Guangya,Tian, Hanwen,Wang, Xiaoying,Chen, Shanze,Wang, Yi,Li, Jingyu,Chen, Junli,Huang, Ning

, (2016)

Uropathogenic Escherichia coli (UPEC) biofilm formation enables the organism to avoid the host immune system, resist antibiotics, and provide a reservoir for persistent infection. Once the biofilm is established, eradication of the infection becomes difficult. Therefore, strategies against UPEC biofilm are urgently required. In this study, we investigated the effect of allicin, isolated from garlic essential oil, on UPEC CFT073 and J96 biofilm formation and dispersal, along with its effect on UPEC adhesion ability and swimming motility. Sub-inhibitory concentrations (sub-MICs) of allicin decreased UPEC biofilm formation and affected its architecture. Allicin was also capable of dispersing biofilm. Furthermore, allicin decreased the bacterial adhesion ability and swimming motility, which are important for biofilm formation. Real-time quantitative polymerase chain reaction (RT-qPCR) revealed that allicin decreased the expression of UPEC type 1 fimbriae adhesin gene fimH. Docking studies suggested that allicin was located within the binding pocket of heptyl —-D-mannopyrannoside in FimH and formed hydrogen bonds with Phe1 and Asn135. In addition, allicin decreased the expression of the two-component regulatory systems (TCSs) cognate response regulator gene uvrY and increased the expression of the RNA binding global regulatory protein gene csrA of UPEC CFT073, which is associated with UPEC biofilm. The findings suggest that sub-MICs of allicin are capable of affecting UPEC biofilm formation and dispersal, and decreasing UPEC adhesion ability and swimming motility.

Oxygen-to-Oxygen Silyl Migration of α-Siloxy Sulfoxides and Oxidation-Triggered Allicin Formation

Kelly, Shane S.,Shen, Tun-Li,Xian, Ming

supporting information, p. 3741 - 3745 (2021/05/10)

Oxidation of α-siloxy thioethers leads to the formation of the corresponding sulfoxides as unstable intermediates, which undergo an intramolecular oxygen-to-oxygen silyl migration to break the C-S linkage. This process produces silyl protected sulfenic acids and subsequently thiosulfinates. It was used to develop oxidation-triggered allicin donors.

Application of allicin in preparation of anti-saccharomycetes drugs

-

Paragraph 0035-0037, (2021/07/14)

The invention provides application of allicin in preparation of anti-saccharomycetes drugs, and relates to the technical field of medicines. Experiments show that the allicin has a good antibacterial effect on cryptococcus and candida, and the allicin combined with the antifungal drug also has good antibacterial activity on cryptococcus and candida. Experiments also show that allicin achieves a bacteriostatic or bactericidal effect by destroying capsules or cell walls or cell membranes of cryptococcus. The allicin has better activity against cryptococcus in vivo and in vitro. The allicin preparation can be used as a medicine which is safe, effective, small in toxic and side effects and low in price and is used for clinically treating fungal infectious diseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 539-86-6